Legal Document

Title: Circular 19/2014/TT-BYT Management of addictive drugs, psychotropic drugs, and drug precursors

Type: Circular

Issuing Agency: Ministry of Health

Responsible Agency: Ministry of Health

Issuing Date: 02-06-2014

Chapter I

GENERAL REGULATIONS

Article 1. Scope and regulated entities

This Circular deals with activities pertaining to addictive drugs, psychotropic drugs, drug precursors, commercial combined drugs that contain addictive ingredients, commercial combined drugs that contain psychotropic ingredients, commercial combined drugs that contain drug precursors used for healthcare, analysis, testing, and scientific research by organizations and individuals (hereinafter referred to as entities) in Vietnam and overseas.

Article 2. Interpretation of terms

In this Circular, the terms below are construed as follows:

1. Addictive drugs include:

a) Raw materials that contain addictive ingredients listed in Appendix I enclosed herewith.

b) Semi-finished products that contain any of the addictive ingredients listed in Appendix I enclosed herewith.

c) Commercial drugs that contain any of the addictive ingredients listed in Appendix I enclosed herewith, regardless of concentration.

d) Commercial drugs that contain an addictive ingredient in combination with other active ingredients, the concentration of additive ingredients in which is higher than the level prescribed in Appendix II enclosed herewith.

dd) Commercial drugs that contain an addictive ingredient in combination with other addictive ingredients; commercial drugs that contain an addictive ingredient in combination with psychotropic ingredients; commercial drugs that contain an addictive ingredient in combination with a drug precursor; commercial drugs that contain an addictive ingredient in combination with psychotropic ingredients and drug precursors, regardless of concentration of addictive ingredients, psychotropic ingredients, and drug precursors.

2. Finished addictive drugs are drugs specified in Points c, d, and dd Clause 1 of this Article.

3. Commercial combined drugs that contain addictive ingredients are commercial drugs that satisfy all requirements below:

a) Contain active ingredients other than addictive ingredients, psychotropic ingredients, and drug precursors;

b) Contain addictive ingredients; or contain addictive ingredients in combination with psychotropic ingredients; or contain addictive ingredients in combination with drug precursors; or contain addictive ingredients in combination with psychotropic ingredients and drug precursor;

c) Concentration of addictive ingredients, psychotropic ingredients, and drug precursors does not exceed the levels prescribed in Appendices II, IV and VI enclosed herewith.

4. Psychotropic drugs include:

a) Raw materials that contain any of the psychotropic ingredients listed in Appendix III enclosed herewith.

b) Semi-finished products that contain any of the psychotropic ingredients listed in Appendix III enclosed herewith.

c) Commercial drugs that contain any of the psychotropic ingredients listed in Appendix III enclosed herewith, regardless of concentration.

d) Commercial drugs that contain a psychotropic ingredient in combination with other active ingredients, the concentration of psychotropic ingredients in which is higher than the level prescribed in Appendix IV enclosed herewith.

dd) Commercial drugs that contain a psychotropic ingredient in combination with other psychotropic ingredients; or commercial drugs that contain psychotropic ingredients in combination with drug precursors, regardless of concentration.

5. Finished psychotropic drugs are drugs specified in Points c, d, and dd Clause 4 of this Article.

6. Commercial combined drugs that contain psychotropic ingredients are commercial drugs that satisfy all requirements below:

a) Contain active ingredients other than addictive ingredients, psychotropic ingredients and drug precursors;

b) Contain psychotropic ingredients or psychotropic ingredients in combination with drug precursors;

c) Concentration of psychotropic ingredients and drug precursors does not exceed the levels prescribed in Appendices IV and VI enclosed herewith.

7. Drug precursors include:

a) Raw materials that contain any of the drug precursors listed in Appendix V enclosed herewith.

b) Semi-finished products that contain any of the drug precursors listed in Appendix V enclosed herewith.

c) Commercial drugs that contain any of the drug precursors listed in Appendix V enclosed herewith, regardless of concentration.

d) Commercial drugs that contain a drug precursor in combination with other active ingredients, the concentration of the drug precursor in which is higher than the level prescribed in Appendix VI enclosed herewith.

dd) Commercial drugs that contain a drug precursor in combination with other drug precursors, regardless of concentration.

8. Commercial precursor drugs are drugs specified in Points c, d, and dd Clause 7 of this Article.

9. Commercial combined drugs that contain drug precursors are are commercial drugs that satisfy all requirements below:

a) Contain active ingredients other than addictive ingredients, psychotropic ingredients and drug precursors;

b) Contain drug precursors the concentration of which does not exceed the levels prescribed in Appendix VI enclosed herewith.

APPENDIX I

ADDICTIVE INGREDIENTS

No.	INTERNATIONAL NAME	SCIENTIFIC NAME
1.	ACETYLDIHYDROCODEIN	(5 a, 6 a)- 4,5- epoxy-3- methoxy-17 methyl- morphinan-6-yl-acetat
2.	ALFENTANIL	N-[1-[2-(4-ethyl-4,5- dihydro-5-oxo-1 H-tetrazol-1-yl) ethyl]-4- (methoxymethyl)-4-piperidinyl]- N- Phenylpropanamide
3.	ALPHAPRODINE	a- 1,3- dimethyl-4- phenyl-4- propionoxypiperidine
4.	ANILERIDINE	1- para-aminophenethyl-4- phenylpiperidine-4- carboxylic acid ethyl ester)
5.	BEZITRAMIDE	(1-(3- cyano- 3,3- diphenylpropyl)- 4 (2- oxo- 3- propionyl-1- benzimidazolinyl)- piperidine)
6.	BUTORPHANOL	(-)- 17- (cyclobutylmethyl) morphinan- 3,14 diol
7.	CIRAMADOL	(-)-2- (a- Dimethylamino-3- hydroxybenzyl) Cyclohexanol
8.	COCAINE	Methyl ester of benzoylecgonine
9.	CODEINE	(3- methylmorphine)
10.	DEXTROMORAMIDE	((+)-4 [2- methyl-4- oxo-3,3- diphnyl-4 (1- pyrrolidinyl)- butyl]- morpholine)
11.	DEZOCIN	(-)- 13 b- Amino- 5,6,7,8,9,10,11 a, 12 octahydro- 5a- methyl-5, 11- methanobenzo- cyclodecen-3- ol
12.	DIFENOXIN	(1- (3 cyano- 3,3- Diphenylpropyl)- 4- Phenylisonipecotic acid
13.	DIHYDROCODEIN	6- hydroxy- 3- methoxy-N- methyl-4,5- epoxy- morphinan
14.	DIPHENOXYLATE	1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid ethyl ester
15.	DIPIPANONE	4,4- Diphenyl-6- Piperidino-3- heptanone.
16.	DROTEBANOL	(3,4- Dimethoxy- 17- Methyl morphinan-6 b, 14 diol)
17.	ETHYL MORPHIN	3- Ethylmorphine
18.	FENTANYL	(1- Phenethyl-4-N- Propionylanilinopiperidine)
19.	HYDROMORPHONE	(Dihydromorphinone)
20.	KETOBEMIDON	(4- meta- hydroxyphenyl-1- methyl-4- propionylpiperidine)
21.	LEVOMETHADON	(3- Heptanone, 6- (dimethylamino)-4,4- Diphenyl, (R)
22.	LEVORPHANOL	((-)- 3- hydroxy- N- methylmorphinan)
23.	MEPTAZINOL	(3(3- Ethyl-1- methylperhydroazepin-3- yl) phenol
24.	METHADONE	(6- dimethylamino- 4,4- diphenyl-3- heptanone)
25.	MORPHINE	Morphinan-3,6 diol, 7,8-didehydro- 4,5- epoxy-17 methyl - (5 a, 6 a)
26.	MYROPHINE	MyristylBenzylmorphine
27.	NALBUPHIN	17- Cyclobutylmethyl- 7,8- dihydro- 14- hydroxy- 17- normorphine
28.	NICOCODINE	Morphinan- 6- ol, 7,8- Dihydrro- 4,5- epoxy- 3- methoxy- 17- methyl- 3- pyridin mecarboxxylate (ester), ( 5a, 6a)
29.	NICODICODINE	6- Nicotinyldihydrocodeine
30.	NICOMORPHINE	3,6- Dinicotinylmorphine)
31.	NORCODEINE	N- Dimethylcodein
32.	OXYCODONE	(14- hydroxydihydrocodeinone)
33.	OXYMORPHONE	(14- hydroxydihydromorphinone)
34.	PETHIDINE	(1- methyl-4- phenylpiperidine-4- carboxylic acid ethyl ester)
35.	PHENAZOCINE	(2’- Hydroxy-5,9- Dimethyl-2- Phenethyl-6,7- Benzomorphan)
36.	PHOLCODIN	(Morpholinylethylmorphine)
37.	PIRITRAMIDE	(1-(3- cyano-3,3- diphenylpropyl-4-(1- piperidino)- piperidine- 4- carboxylic acid amide)
38.	PROPIRAM	( N- ( 1- Methyl- 2 piperidinoethyl- N- 2- pyridyl Propionamide)
39.	REMIFENTANIL	1-(2-methoxy carbonylethyl)-4-(phenylpropionylamino)piperidine-4-carboxylic acid methyl ester
40.	SUFENTANIL	(N-[4- (methoxymethyl)-1- [2- (2- thienyl)- ethyl]-4- piperidyl]- propionanilide)
41.	THEBACON	( Acetyldihydrocodeinone)
42.	TONAZOCIN MESYLAT	(+)-1- [( 2R,6S,11S*)- 1,2,3,4,5,6- hexahydro- 8- hydroxy- 3,6,11- trimethyl- 2,6- methano-3- Benzazocin- 11- yl]-3-one-methanesulphonate
43.	TRAMADOL	(+)- Trans- 2- Dimethylaminomethyl-1-(3- methoxy phenyl) cyclohexan-1-ol

* This Table includes:

- Esters and ethers of substances in the Table if they are not enumerated in other Tables, provided such esters and ethers exist.

- Salts of substances in this Table, including salts of esters, ethers, and isomers thereof, provided such salts exist.

APPENDIX II

LIMITS ON ADDICTIVE INGREDIENTS IN COMMERCIAL COMBINED DRUGS

No.	NAME OF ADDICTIVE INGREDIENT	CONCENTRATION IN THE FORM OF ALKALI IN A DIVIDED DOSE (Expressed as mg)	CONCENTRATION IN THE FORM OF ALKALI IN A SINGLE-DOSE PRODUCTS (Expressed as %)
1.	ACETYLDIHYDROCODEIN	100	2.5
2.	COCAINE		0.1
3.	CODEINE	100	2.5
4.	DIFENOXIN	Not exceeding 0.5 mg of Difenoxin and with at least 0.025 mg of Atropin Sulfate in a divided dose
5.	DIPHENOXYLATE	Not exceeding 2.5 mg of Difenoxylat and with at least 0.025 mg of Atropin Sulfate in a divided dose
6.	DIHYDROCODEIN	100	2.5
7.	ETHYL MORPHIN	100	2.5
8.	NICODICODIN	100	2.5
9.	NORCODEIN	100	2.5
10.	PHOLCODIN	100	2.5
11.	PROPIRAM	100	2.5
12.	MORPHINE		0.2 morphine expressed as pure morphine base
13.	TRAMADOL	37.5

APPENDIX III

PSYCHOTROPIC INGREDIENTS

No.	INTERNATIONAL NAME	OTHER COMMON NAME	SCIENTIFIC NAME
1.	ALLOBARBITAL		5,5-diallylbarbituric acid
2.	ALPRAZOLAM		8- chloro -1- methy -6- phenyl – 4H -s- triazolo [4,3-a] [1,4] benzodiazepine
3.	AMFEPRAMONE	Diethylpropion	2-(diethylamino) propiophenone
4.	AMINOREX		2- amino-5- phenyl- 2-oxazoline
5.	AMOBARBITAL		5-ethyl-5-isopentylbarbituric acid
6.	BARBITAL		5,5-diethylbarbituric acid
7.	BENZFETAMINE	Benzphetamine	N-benzyl-N, a-dimethylphenethylamine
8.	BROMAZEPAM		7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1,4-benzodiazepin-2-one
9.	BROTIZOLAM		2- bromo-4-(o-chlorophenyl)-9 methyl-6H-thieno(3,2-f)-s-triazolo( 4,3- a)(1,4) diazepine
10.	BUPRENORPHINE		21-cyclopropyl-7-a[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydro oripavine
11.	BUTALBITAL		5-allyl-5-isobutylbarbituric acid
12.	BUTOBARBITAL		5-butyl-5- ethylbarbituric acid
13.	CAMAZEPAM		7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one dimethylcarbamate (ester)
14.	CHLODIAZEPOXID		7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide
15.	CATHINE	(+)-norpseudo-ephedrine	(+)-(R)-a-[(R)-1-aminoethyl]benzyl alcohol
16.	CLOBAZAM		7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepin-2,4 (3H,5H) dione
17.	CLONAZEPAM		5- (o-chlorophenyl)-1,3-dihydro-7- nitro- 2H -1,4 -benzodiazepine-2 –one
18.	CLORAZEPATE		7- chloro - 2,3 - dihydro - 2 - oxo -5-phenyl-1H-1,4-benzodiazepine -3-carbocilic acid
19.	CLOTIAZEPAM		5-(o-chlorophenyl)-7-ethyl-1,3 dihydro-1 methyl-2H-thieno[2,3e]-1,4 -diazepin -2- one
20.	CLOXAZOLAM		10-chloro-11b-(o-chlorophenyl)2,3,7,11b-tetrahydrooxazolo-[3,2-d] [1,4]benzodiazepin-6(5H) –one
21.	DELORAZEPAM		7-chloro-5- (o-chlorophenyl)-1,3 dihydro-2H-1,4 benzodiazepin-2 – one
22.	DIAZEPAM		7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4 benzodiazepin-2 – one
23.	ESTAZOLAM		8-chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepin
24.	ETHCHLORVYNOL		1 - chloro -3- ethyl -1- penten -4 - yn -3-ol
25.	ETHINAMATE		1- ethynylcyclohexanol carbamate
26.	ETHYLLOFLAZEPATE		ethyl -7- chloro -5- (0-fluorophenyl) -2,3 - dihydro -2 - oxo -1H-1,4 -benzodiazepine -3- carboxylate
27.	ETILAMFETAMINE	N-ethylamphetamine	N-ethyl-a-methylphenethylamine
28.	FENCAMFAMIN		N- ethyl-3- phenyl-2- norbornanamine
29.	FENPROPOREX		(+) –3- [ (a- methylphenethyl) amino] propionitrile
30.	FLUDIAZEPAM		7-chloro -5- (o-fluorophenyl) -1,3-dihydro -1- methyl- 2H - 1,4- benzodiazepin -2- one
31.	FLUNITRAZEPAM		5-(o-fluorophenyl) -1,3 -dihydro-1- methyl -7- nitro-2H-1,4 benzodiazepin -2- one
32.	FLURAZEPAM		7-chloro-1-[2-(diethylamino)ethyl] -5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin -2 – one
33.	GLUTETHIMID		2-ethyl-2-phenylglutarimide
34.	HALAZEPAM		7-chloro-1,3- dihydro -5- phenyl-1-(2,2,2 -trifluoroethyl)-2H-1,4-benzodiazepin -2 – one
35.	HALOXAZOLAM		10-bromo-11b -(o-fluorophenyl)- 2,3,7,11b tetrahydrooxazolo [3,2-d] [1,4] benzodiazepin -6 (5H) –one
36.	KETAZOLAM		11-chloro -8,12b - (dihydro - 2,8 - dimethyl - 12b - phenyl - 4H -[1,3] oxazino[3,2-d][1,4] benzodiazepin-4,7 (6H)-dione
37.	KETAMIN		(+) –2- (2-Clorophenyl)-2-methylaminocyclohexanone.
38.	LEFETAMIN	SPA	(-)-N,N-dimethyl-1,2-diphenylethylamine
39.	LOPRAZOLAM		6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl) methylene] -8-nitro-1H-imidazol[1,2-a] [1,4] benzodiazepin -1 –one
40.	LORAZEPAM		7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4 benzodiazepin -2 – one
41.	LORMETAZEPAM		7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4 benzodiazepin -2 – one
42.	MAZINDOL		5-(p-chlorophenyl)- 2,5-dihydro -3H-imidazo[2,1-a] isoindol-5-ol
43.	MEDAZEPAM		7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4 benzodiazepine
44.	MEFENOREX		N-(3- chloropropyl)- a - methylphenethylamine
45.	MEPROBAMAT		2-methyl-2-propyl - 1,3-propanediol, dicarbamate
46.	MESOCARB		3- (a methylphenethyl)- N- (phenylcarbamoyl) sydnone imine
47.	METHYLPHENIDATE		Methyl a -phenyl-2-piperidineacetate
48.	METHYLPHENO-BARBITAL		5-ethyl-1-methyl -5- phenylbarbituric acid
49.	METHYPRYLON		3,3 diethyl-5- methyl-2,4 piperydine- dione
50.	MIDAZOLAM		8- chloro- -6- (o-fluorophenyl) -1-methyl-4H-imidazol[1,5-a][1,4] benzodiazepine
51.	NIMETAZEPAM		1,3 dihydro -1- methyl-7-nitro-5-phenyl-2H-1,4 benzodiazepin-2-one
52.	NITRAZEPAM		1,3 dihydro -7-nitro-5-phenyl-2H-1,4 benzodiazepin-2-one
53.	NORDAZEPAM		7-chloro- 1,3 dihydro-5- phenyl-2H-1,4 benzodiazepin-2-one
54.	OXAZEPAM		7-chloro- 1,3 dihydro- 3hydroxy-5- phenyl-2H-1,4 benzodiazepin-2-one
55.	OXAZOLAM		10-chloro--2,3,7,11b- tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d] [1,4] benzodiazepin-6(5H) –one
56.	PENTAZOCIN		(2R,6R,11R*)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
57.	PENTOBARBITAL		5-ethyl-5-(1-methylbutyl) barbituric acid
58.	PHENDIMETRAZIN		(+)-(2S,3S)-3,4-dimethyl-2-phenylmorpholine
59.	PHENOBARBITAL		5-ethyl-5-phenylbarbituric acid
60.	PHENTERMIN		a,a- dimethylphenethylamine
61.	PINAZEPAM		7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one
62.	PRAZEPAM		7-chloro -1- (cyclopylmethyl) - 1,3 - dihydro -5- phenyl -2H- 1,4-benzodiazepin-2-one
63.	PYROVALERONE		4’-methyl-2-(1-pyrrolidinyl) valerophenone
64.	SECBUTABARBITAL		5-sec-butyl-5-ethylbarbituric acid
65.	TEMAZEPAM		7- chloro - 1,3 - dihydro -3-hydroxy-1 -methyl-5-phenyl -2H- 1,4-benzodiazepin -2- one
66.	TETRAZEPAM		7-chloro-5-(1-cyclohexen-1-yl)-1,3dihydro-1-methyl-2H-1,4 benzodiazepin -2- one
67.	TRIAZOLAM		8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4] benzodiazepin
68.	VINYLBITAL		5-(1-methylbutyl)-5-vinylbarbituric acid
69.	ZOLPIDEM		N,N,6- trimethyl-2-p- tolylimidazol [1,2-a] pyridine-3- acetamide

* This Table includes salts of substances therein, provided such salts exist.

APPENDIX IV

LIMITS ON PSYCHOTROPIC INGREDIENTS IN COMMERCIAL COMBINED DRUGS

No.	NAME OF PSYCHOTROPIC INGREDIENT AND PRECURSOR	MAXIMUM CONCENTRATION IN A DIVIDED DOSE
1.	ALLOBARBITAL	10mg
2.	ALPRAZOLAM	0.25mg
3.	AMOBARBITAL	10mg
4.	BARBITAL	10mg
5.	BROMAZEPAM	1mg
6.	BROTIZOLAM	0.25mg
7.	BUTOBARBITAL	10mg
8.	CAMAZEPAM	5mg
9.	CHLODIAZEPOXID	5mg
10.	CLOBAZAM	5mg
11.	CLONAZEPAM	0.5mg
12.	CLORAZEPAT	10 mg
13.	CLOTIAZEPAM	5mg
14.	DIAZEPAM	5mg
15.	ESTAZOLAM	0.5mg
16.	FLUDIAZEPAM	0.5mg
17.	FLUNITRAZEPAM	0.5mg
18.	FLURAZEPAM	5mg
19.	HALAZEPAM	5mg
20.	KETAZOLAM	5mg
21.	LOPRAZOLAM	0.25mg
22.	LORAZEPAM	0.5mg
23.	LORMETAZEPAM	0.25mg
24.	MEPROBAMAT	100mg
25.	MEDAZEPAM	5mg
26.	METHYLPHENOBARBITAL	10mg
27.	MIDAZOLAM	5mg
28.	NITRAZEPAM	5mg
29.	NORDRAZEPAM	0.25mg
30.	OXAZEPAM	10mg
31.	PARAZEPAM	5mg
32.	PENTOBARBITAL	10mg
33.	PHENOBARBITAL	25 mg
34.	SECBUTABARBITAL	10mg
35.	TEMAZEPAM	25mg
36.	TETRAZEPAM	5mg
37.	VINYLBITAL	10mg
38.	CLOXAZOLAM	1mg
39.	DELORAZEPAM	0.25mg
40.	ETHYLCLOFLAZEPAT	0.25mg
41.	NIMETAZEPAM	0.25mg
42.	OXAZOLAM	5mg
43.	PINAZEPAM	1mg

APPENDIX V

DRUG PRECURSORS

No.	INTERNATIONAL NAME	SCIENTIFIC NAME
1.	EPHEDRINE	([R-(R, S)]--[1-(methylamino)ethyl]-Benzenemethanol
2.	N-ETHYLEPHEDRIN	1-Ethylephedrin
3.	N-METHYLEPHEDRIN/ METHYLEPHEDRIN/ DL-METHYLEPHEDRIN	(1R, 2S)-2- (dimethylamino)-1- phenyl- propanol
4.	PSEUDOEPHEDRINE	[S-(R, R)]--[1-(methylamino)ethyl]-Benzenemethanol
5.	ERGOMETRINE	Ergoline-8-carboxamide,9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methy- [8 b(s)].
6.	ERGOTAMINE	Ergotaman-3’,6’,18’-trione,12’-hydroxy-2’-methyl-5’-(phenylmethyl)-(5)
7.	N-ETHYLPSEUDOEPHEDRIN	Ethyl methyl amino – phenyl – propane - 1 - ol
8.	N-METHYLPSEUDOEPHEDRIN	Dimethylamino – phenyl – propane – 1 - ol

* This Table includes salts of substances therein, provided such salts exist.

APPENDIX VI

LIMITS ON PRECURSORS IN COMMERCIAL COMBINED DRUGS

No.	PRECURSOR NAME	MAXIMUM CONCENTRATION IN A DIVIDED DOSE	MAXIMUM CONCENTRATION IN A SINGLE DOSE
1.	EPHEDRINE	50 mg	1.5%
2.	ERGOMETRINE	0.125 mg
3.	N- ETHYLEPHEDRIN	12.5 mg
4.	N- METHYLEPHEDRIN	31.1 mg
5.	ERGOTAMINE	01 mg
6.	PSEUDOEPHEDRINE	120 mg	0.5%

APPENDIX VII

LIST OF EXPORTERS, IMPORTERS, AND SUPPLIERS OF ADDICTIVE DRUGS, PSYCHOTROPIC DRUGS, AND DRUG PRECURSORS

No.	COMPANY'S NAME
1.	Central Pharmaceutical Company No. 1
2.	Central Pharmaceutical Company No. 2
3.	Central Pharmaceutical Company No. 3
4.	Sapharco
5.	YTECO

Download English: Circular 19/2014/TT-BYT Management of addictive drugs, psychotropic drugs, and drug precursors

Download Vietnamese: Circular 19/2014/TT-BYT Management of addictive drugs, psychotropic drugs, and drug precursors

List Measures/Standards

Name	Description	Status	Measures/Standards	Measure Class
Importing finished addictive drugs, psychotropic substances, precursor substances bearing sale numbers	Activities related to addictive drugs used in medicine, analysis, testing, and scientific research enumerated in the List of Addictive drugs	Active	Measure	Goods
Importing finished products containing addictive elements bearing sale registration numbers	Finished drugs containing various active elements and substances in which an addictive substance is combined with other substances (that are not addictive drugs, psychotropic substances, precursor substances )	Active	Measure	Goods
Importing addictive drugs without registration numbers	Activities relating to addictive drugs used in medicine, analysis, testing, and scientific research without registration numbers	Active	Measure	Goods
Importing unregistered addictive drugs under the specific needs of the hospital	Activities relating to addictive drugs used in medicine, analysis, testing, and scientific research without registration numbers	Active	Measure	Goods
Finished combined drugs containing addictive elements without registration numbers	Activities relating to addictive drugs used in medicine, analysis, testing, and scientific research without registered numbers	Active	Measure	Goods
Exporting addictive raw materials, psychotropic substances, precursor substances	Exporting addictive raw materials, psychotropic substances, precursor substances	Active	Measure	Goods
Exporting finished addictive drugs, psychotropic substances, precursor substances with registration numbers	Exporting finished addictive drugs, psychotropic substances, precursor substances with registration numbers	Active	Measure	Goods
Exporting materials, finished addictive drugs, psychotropic substances, precursor substances without registration numbers	Exporting materials, finished addictive drugs, psychotropic substances, precursor substances without registration numbers	Active	Measure	Goods
Exporting materials, finished addictive drugs, psychotropic substances, precursor substances without registration numbers in combination form	Exporting materials, finished addictive drugs, psychotropic substances, precursor substances without registration numbers in combination form	Active	Measure	Goods
Exporting combined finished addictive drugs, psychotropic, substances used for drug production without registration numbers	Exporting combined finished addictive drugs, psychotropic, substances used for drug production without registration numbers	Active	Measure	Goods